The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.120.6.578

A study of the effects of discontinuing or reducing maintenance medication in chronic schizophrenic men provided an opportunity to evaluate the clinical usefulness of one of the rapid semi-quantitative urine tests (FPN). The rate of excretion of chlorpromazine and thioridazine after placebos had been substituted was determined and the effects of intermittent administration of drugs were observed. The FPN test performed as expected, also providing some interesting information about patients' drug taking behavior. The lower colorimetric readings obtained with thioridazine were most interesting but do not preclude the use of the test done with strict attention to detail in a clinical setting. As the FPN test is a qualitative procedure, its semi-quantitative potential as used in this study should be considered an approximation yielding usable comparative results.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.